Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaolan Ling

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Molecular Pharmaceutics|August 20, 2024
Templated Nucleation of Clotrimazole and Ketoprofen on Polymer SubstratesMichael A Bellucci, Lina Yuan, Grahame R Woollam, et al.
Drug Discovery Today|August 27, 2013
Driving external chemistry optimization via operations management principlesF Christopher Bi, Heather N Frost, Xiaolan Ling, et al.
BMC Cancer|August 27, 2025
Prognostic value of nutritional risk assessment indices in patients with digestive system tumorsTingting Zeng, Xiaolan Ling, Si Chen, et al.
Cancer Biology & Therapy|September 5, 2008
Apogossypolone, a nonpeptidic small molecule inhibitor targeting Bcl-2 family proteins, effectively inhibits growth of diffuse large cell lymphoma cells in vitro and in vivoYuan Sun, Jack Wu, Amro Aboukameel, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2008
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibitionSanjeev Shangary, Dongguang Qin, Donna McEachern, et al.
Journal of Medicinal Chemistry|April 30, 2021
Discovery and Optimization of DNA Gyrase and Topoisomerase IV Inhibitors with Potent Activity against Fluoroquinolone-Resistant Gram-Positive BacteriaGuillaume Lapointe, Colin K Skepper, Lauren M Holder, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Molecular Pharmaceutics|August 20, 2024
Templated Nucleation of Clotrimazole and Ketoprofen on Polymer SubstratesMichael A Bellucci, Lina Yuan, Grahame R Woollam, et al.
Drug Discovery Today|August 27, 2013
Driving external chemistry optimization via operations management principlesF Christopher Bi, Heather N Frost, Xiaolan Ling, et al.
BMC Cancer|August 27, 2025
Prognostic value of nutritional risk assessment indices in patients with digestive system tumorsTingting Zeng, Xiaolan Ling, Si Chen, et al.
Cancer Biology & Therapy|September 5, 2008
Apogossypolone, a nonpeptidic small molecule inhibitor targeting Bcl-2 family proteins, effectively inhibits growth of diffuse large cell lymphoma cells in vitro and in vivoYuan Sun, Jack Wu, Amro Aboukameel, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2008
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibitionSanjeev Shangary, Dongguang Qin, Donna McEachern, et al.
Journal of Medicinal Chemistry|April 30, 2021
Discovery and Optimization of DNA Gyrase and Topoisomerase IV Inhibitors with Potent Activity against Fluoroquinolone-Resistant Gram-Positive BacteriaGuillaume Lapointe, Colin K Skepper, Lauren M Holder, et al.
Pageof 1